Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

IDEAYA Biosciences to Present First Median Overall Survival Data from Phase 2 Trial of the Darovasertib / Crizotinib Combination in Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress

(NASDAQ:IDYA) SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced that an abstract wit...

How does the median overall survival data for this regimen compare to existing treatments for metastatic uveal melanoma and to other pipeline candidates from competitors? When is IDEAYA planning to submit additional data or seek regulatory approval for the combination therapy, and what milestones could drive the stock in the next 12 months? What are the expected efficacy and safety results from the darovasertib + crizotinib Phase 2 trial and how will they affect market perception of IDEAYA Biosciences?
Symbol: IDYA
Clinical trials
18 days ago
Read more prnewswire

Tesla asks for $243 million verdict to be tossed in fatal Autopilot crash suit

(NASDAQ:TSLA) The Tesla collision in Key Largo, Florida, killed 22-year-old Naibel Benavides and severely injured her boyfriend, Dillon Angulo.

Could the outcome of this case trigger increased regulatory scrutiny or influence the pace of autonomous driving rollouts across the industry? What effect might this lawsuit have on investor sentiment toward Tesla’s Autopilot technology and future vehicle demand? How will the potential reduction of the $243 million verdict affect Tesla’s financial exposure and earnings guidance?
Symbol: TSLA
Lawsuits
18 days ago
Read more cnbc_tech

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors – SMLR

(NASDAQ:SMLR) NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Semler Scienti...

How might this legal action influence investor sentiment and liquidity for SMLR in the short to medium term? What specific allegations are being made and could they indicate deeper operational or financial issues at Semler Scientific? How likely is the lawsuit to result in a settlement or judgment that could materially affect SMLR's share price?
Symbol: SMLR
Lawsuits
18 days ago
Read more businesswire